Quick Answer
Edwards Lifesciences Corp reported Stockholders Equity of $10.34 billion for fiscal year 2025.
Edwards Lifesciences Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $10.34B | +3.4% |
| 2024 | $10.00B | +50.4% |
| 2023 | $6.65B | +14.5% |
| 2022 | $5.81B | -0.5% |
| 2021 | $5.84B | +27.6% |
| 2020 | $4.57B | +10.3% |
| 2019 | $4.15B | +32.1% |
| 2018 | $3.14B | +6.2% |
| 2017 | $2.96B | +12.9% |
| 2016 | $2.62B | +4.6% |
| 2015 | $2.50B | +14.2% |
| 2014 | $2.19B | +41.9% |
| 2013 | $1.54B | +5.3% |
| 2012 | $1.47B | +10.5% |
| 2011 | $1.33B | +1.5% |
| 2010 | $1.31B | +13.0% |
| 2009 | $1.16B | +31.8% |
| 2008 | $878.80M | +5.2% |
| 2007 | $835.00M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.21B | +6.9% | -3.2% |
| June 30, 2025 | $10.55B | +41.8% | +4.1% |
| March 31, 2025 | $10.13B | +42.3% | +1.3% |
| December 31, 2024 | $10.00B | +50.4% | +4.7% |
| September 30, 2024 | $9.55B | +43.4% | +28.3% |
| June 30, 2024 | $7.44B | +16.7% | +4.5% |
| March 31, 2024 | $7.12B | +19.1% | +7.0% |
| December 31, 2023 | $6.65B | +14.5% | -0.1% |
- Edwards Lifesciences Corp showed an increase of +3.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2007–2025 period, Edwards Lifesciences Corp’s stockholders equity has grown by 1138.0% (from $835.00 million to $10.34 billion).
- The most recent figure is from Edwards Lifesciences Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: